# An Adherence Tool to Manage Narcotic -Addicted HIV Patients

> **NCT02194764** · NA · COMPLETED · sponsor: **Xhale Assurance** · enrollment: 8 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** Naltrexone and 2-butanol
- **DRUG:** 2-butanol which is encapsulated (size 3 capsule) plus 50 mg of naltrexone (HCl form)

## Key facts

- **NCT ID:** NCT02194764
- **Lead sponsor:** Xhale Assurance
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02194764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02194764, "An Adherence Tool to Manage Narcotic -Addicted HIV Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02194764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*